CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+21.32%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.39B
AUM Growth
+$1.39B
(+12%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
65
New
8
Increased
5
Reduced
40
Closed
4
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$43.4M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$27.3M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$24.8M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$17.2M |
| 5 |
Zai Lab
ZLAB
|
$9.25M |
Top Sells
| 1 |
Vanda Pharmaceuticals
VNDA
|
$18.2M |
| 2 |
Quanterix
QTRX
|
$17M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$13.3M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$11.8M |
| 5 |
MTVA
MetaVia Inc. Common Stock
MTVA
|
$10.6M |
Sector Composition
| 1 | Healthcare | 95.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $21.2M | 1.38% | 831,000 | – | – |
|
|
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $18.9M | 1.23% | 410,000 -40,000 | -9% | -$1.84M |
|
28
Incyte
INCY
$16.5B
| $18M | 1.17% | 260,000 +60,000 | +30% | +$4.14M |
|
|
29
Zai Lab
ZLAB
$3.68B
| $15.7M | 1.02% | 808,166 +475,000 | +143% | +$9.25M |
|
30
argenx
ARGX
$43.6B
| $14.4M | 0.94% | 190,000 -88,536 | -32% | -$6.71M |
|
31
Inspire Medical Systems
INSP
$2.77B
| $12.6M | 0.82% | 300,000 -25,000 | -8% | -$1.05M |
|
|
BHVN
32
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $9.76M | 0.63% | 260,000 -24,735 | -9% | -$929K |
|
|
ARRY
33
DELISTED
Array Biopharma Inc
ARRY
| $9.12M | 0.59% | 600,000 -68,743 | -10% | -$1.04M |
|
|
RUBY
34
DELISTED
Rubius Therapeutics, Inc
RUBY
| $8.75M | 0.57% | +364,559 | New | +$8.75M |
|
|
CNST
35
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $8.56M | 0.56% | +1,271,687 | New | +$8.56M |
|
|
SPPI
36
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $8.4M | 0.55% | 500,000 -700,000 | -58% | -$11.8M |
|
|
AMRN
37
Amarin Corp
AMRN
$311M
| $8.14M | 0.53% | +500,000 | New | +$8.14M |
|
38
Minerva Neurosciences
NERV
$16.5M
| $7.63M | 0.5% | 607,903 | – | – |
|
39
Replimune Group
REPL
$422M
| $7.53M | 0.49% | +467,792 | New | +$7.53M |
|
40
Aclaris Therapeutics
ACRS
$209M
| $7.26M | 0.47% | 500,000 -25,538 | -5% | -$371K |
|
41
Abeona Therapeutics
ABEO
$350M
| $6.4M | 0.42% | 500,000 -49,404 | -9% | -$632K |
|
|
CFRX
42
DELISTED
ContraFect Corporation
CFRX
| $6.21M | 0.4% | 3,000,000 -392,234 | -12% | -$812K |
|
43
Scholar Rock
SRRK
$3.14B
| $5.41M | 0.35% | 210,078 | – | – |
|
44
Heron Therapeutics
HRTX
$207M
| $5.38M | 0.35% | 170,000 -21,108 | -11% | -$668K |
|
45
Y-mAbs Therapeutics
YMAB
$388M
| $5.31M | 0.35% | +200,000 | New | +$5.31M |
|
|
BOLD
46
DELISTED
Audentes Therapeutics, Inc
BOLD
| $4.95M | 0.32% | 125,000 -197,945 | -61% | -$7.84M |
|
|
TBIO
47
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $4.55M | 0.3% | 454,550 | – | – |
|
|
EIDX
48
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $3.85M | 0.25% | 385,846 | – | – |
|
49
Collegium Pharmaceutical
COLL
$1.22B
| $3.69M | 0.24% | 250,000 -36,668 | -13% | -$540K |
|
50
Sangamo Therapeutics
SGMO
$157M
| $3.39M | 0.22% | 200,000 -182,192 | -48% | -$3.09M |
|